1.
Study on Recombinant Nonglycosylated Urokinase-type Plasminogen Activator;
重组非糖基化尿激酶型纤溶酶原激活剂的研究
2.
Expression and Regulation of Urokinase-type Plasminogen Activator in Supraglottic Laryngeal Cancer;
尿激酶型纤溶酶原激活剂在声门上型喉癌中的表达及调节机制
3.
Clinical Study of the Expression of Tissue Factor and Urokinase Plasminogen Activator Receptor in Breast Cancer
组织因子、尿激酶型纤溶酶原激活剂受体在乳腺癌中的表达
4.
Clinical Significance of Measurement of Plasma Urokinase Type Plasminogen Activator and its Receptor in Cancer Patients
癌症患者尿激酶型纤溶酶原激活物及其受体检测的临床意义
5.
The Relationship between the Expression of Yrokinase-type Plasminogen Activator Receptor,and the Infiltration and Metastasis of Gastric Cancer
尿激酶型纤溶酶原激活物受体表达与胃癌浸润和转移过程的关系
6.
Expression of urokinase-type plasminogen activator and its receptor protein in synovial tissues from osteoarthritis
骨关节炎滑膜中尿激酶型纤溶酶原激活物及其受体蛋白的表达
7.
Study on the Transcriptional Regulation of Urokinase Plasminogen Activator in Human Lung Cancer;
尿激酶型纤溶酶原激活物在人肺癌细胞中表达调控的研究
8.
The Experiment Research That the uPA to Suffer from the Relativity with the Arthritis Disease;
尿激酶型纤溶酶原激活物（uPA）与关节炎性疾患相关性的实验研究
9.
Expressions of Survivin and uPA in human cerebral gliomas
脑胶质瘤组织中Survivin和尿激酶型纤溶酶原激活物蛋白的表达
10.
Cloning and Expression of Urokinase Type Plasminogen Activator cDNA
尿激酶型纤溶酶原激活因子cDNA的克隆与原核表达
11.
A Study of the Level of Cyclooxygenase-2 and Urokinase-type Plasminogen Activator in the Left and Right Atrium of Acute Atrial Fibrillation in Canines;
犬急性心房颤动时心房环氧酶-2与尿激酶型纤溶酶原激活物的变化
12.
The Effect of Amiloride-an Inhibitor of Urokinase on the Pathology of Rat COPD Model;
尿激酶型纤溶酶原激活物抑制剂—氨氯吡咪对大鼠COPD模型病理改变的影响
13.
Study of the Roles and Mechanisms of Urokinase-type Plasminogen Activator in Promoting Male Fertility;
尿激酶型纤溶酶原激活因子多环节促雄性生育作用及相关机制探讨实验研究
14.
Treatment of Experimental Hepatic Fibrosis by Combination of Urokinase-type Plasminogen Activator and Hepatocyte Growth Factor Gene Delivery;
尿激酶型纤溶酶原激活剂和肝细胞生长因子联合基因治疗实验性肝纤维化
15.
Significance of Urokinase-type Plasminogen Activator and Urokinase-type Plasminogen Activator Receptor in Synovial Fluid of Patients with Temporomandibular Disorders;
颞下颌关节紊乱病关节液中尿激酶型纤溶酶原激活物及其受体的检测
16.
Expression and Prognostic Significance of Nuclear Factor-kappaBp-65 and uPA in Cervical Carcinoma;
核转录因子-kBp65和尿激酶型纤溶酶原激活剂在人宫颈癌中的表达及预后意义
17.
The Expression of uPA and Endostatin in Human Colorectal Carcinoma and Their Relations to Angiogenesis;
人大肠肿瘤中尿激酶型纤溶酶原激活物和内皮抑素的表达与血管新生的关系
18.
The Preliminary Research of the Effect of External Urokinase-type Plasminogen Activator(uPA) to the Synovial Tissue of Rabbits Keen Joint;
外源性尿激酶型纤溶酶原激活物（uPA）对兔膝关节滑膜影响的初步研究